| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; YI-CHIA LEE ; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; CHIEH-CHANG CHEN ; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
| 2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | | 9 | |
| 2018 | 970?nm low-level laser affects bone metabolism in orthodontic tooth movement | Hsu L.-F.; Tsai M.-H.; Chang B.-E.; Chen Y.-J.; JANE CHUNG-CHEN YAO | Journal of Photochemistry and Photobiology B: Biology | 9 | 8 | |
| 2018 | 970?nm low-level laser affects bone metabolism in orthodontic tooth movement | Hsu L.-F.; Tsai M.-H.; BEI-EN CHANG ; Chen Y.-J.; Yao C.-C.J. | Journal of Photochemistry and Photobiology B: Biology | | 8 | |
| 2018 | 970?nm low-level laser affects bone metabolism in orthodontic tooth movement | Hsu L.-F.; Tsai M.-H.; Chang B.-E.; YI-JANE CHEN ; Yao C.-C.J. | Journal of Photochemistry and Photobiology B: Biology | | 8 | |
| 2011 | ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment | Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; Lu S.-C.; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; CHI-SHIN WU ; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. | Pharmacogenetics and Genomics | 64 | 74 | |
| 2011 | ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment | Lin K.-M.; Chiu Y.-F.; Tsai I.J.; Chen C.-H.; Shen W.W.; Liu S.C.; SHAO-CHUN LU ; Liu C.-Y.; Hsiao M.-C.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu C.-S.; Tsou H.-H.; Tsai M.-H.; Chen C.-Y.; Wang S.-M.; Kuo H.-W.; Hsu Y.-T.; Liu Y.-L. | Pharmacogenetics and Genomics | 61 | 74 | |
| 2020 | ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs | Lee I.T.; Nakayama T.; Wu C.-T.; Goltsev Y.; Jiang S.; Gall P.A.; Liao C.-K.; Shih L.-C.; Schürch C.M.; McIlwain D.R.; Chu P.; Borchard N.A.; Zarabanda D.; Dholakia S.S.; Yang A.; Kim D.; Chen H.; Kanie T.; Lin C.-D.; Tsai M.-H.; Phillips K.M.; Kim R.; Overdevest J.B.; Tyler M.A.; Yan C.H.; Lin C.-F.; Lin Y.-T.; Bau D.-T.; Tsay G.J.; Patel Z.M.; Tsou Y.-A.; Tzankov A.; Matter M.S.; Tai C.-J.; TE-HUEI YEH ; Hwang P.H.; Nolan G.P.; Nayak J.V.; Jackson P.K. | Nature Communications | 84 | 57 | |
| 2014 | ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells | Sher Y.-P.; Wang L.-J.; Chuang L.-L.; Tsai M.-H.; Kuo T.-T.; Huang C.-C.; Chuang E.Y.; LIANG-CHUAN LAI | PLoS ONE | 26 | 28 | |
| 2021 | Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis | Lin M.-C.; Leu Y.-S.; CHUN-JU CHIANG ; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; Chen H.-L.; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; Huang H.-C.; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. | Oral Oncology | 5 | 5 | |
| 2021 | Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis | Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; Chen H.-L.; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; HUAI-CHENG HUANG ; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. | Oral Oncology | | 5 | |
| 2021 | Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis | Lin M.-C.; Leu Y.-S.; Chiang C.-J.; Ko J.-Y.; Wang C.-P.; Yang T.-L.; Chen T.-C.; Chen C.-N.; HSIN-LIN CHEN ; Liao C.-T.; Tsai S.-T.; Lin J.-C.; Chu P.-Y.; Tsai K.-Y.; Tsai M.-H.; Huang H.-C.; Yang M.-H.; Wu Y.-H.; Terng S.-D.; Chien C.-Y.; Liu T.-W.; Lee W.-C.; Lou P.-J. | Oral Oncology | | 5 | |
| 2018 | Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome—A Taiwan Cancer Registry national database analysis | Cheng Y.-J.; Tsai M.-H.; CHUN-JU CHIANG ; Tsai S.-T.; Liu T.-W.; Lou P.-J.; Liao C.-T.; Lin J.-C.; Chang J.T.-C.; Tsai M.-H.; Chu P.-Y.; Leu Y.-S.; Tsai K.-Y.; Terng S.-D.; Chien C.-Y.; Yang M.-H.; Hao S.-P.; Wang C.-C.; Tsai M.-H.; Chen H.H.W.; Kuo C.; Wu Y.-H. | Cancer Medicine | 16 | 14 | |
| 2016 | Alteration of colonic epithelial cell differentiation in mice deficient for glucosaminyl N-deacetylase/N-sulfotransferase 4 | Jao T.-M.; Li Y.-L.; SHU-WHA LIN ; Tzeng S.-T.; Yu I.-S.; Yen S.-J.; Tsai M.-H.; Yang Y.-C. | Oncotarget | 9 | 10 | |
| 2016 | Alteration of colonic epithelial cell differentiation in mice deficient for glucosaminyl N-deacetylase/N-sulfotransferase 4 | Jao T.-M.; Li Y.-L.; Lin S.-W.; Tzeng S.-T.; Yu I.-S.; Yen S.-J.; Tsai M.-H.; YA-CHIEN YANG | Oncotarget | 6 | 10 | |
